⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
globenewswire.com
PSTV
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
globenewswire.com
PSTV
Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
globenewswire.com
PSTV
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
globenewswire.com
PSTV
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
ELV
Plus Therapeutics to Provide Business Update Call on June 30, 2026
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
globenewswire.com
PSTV
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
globenewswire.com
PSTV